ANTIPSYCHOTIC DRUGS MARKET ANALYSIS

Antipsychotic Drugs Market, by Drug Type (First Generation Drugs, Second Generation Drugs, and Third Generation Drugs), by Application (Schizophrenia, Bipolar Disorder, Dementia, Unipolar Depression, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028

Published In : Sep 2023
Code : CMI1196
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Key players focusing on development of novel and innovative therapeutic medication to strengthen their presence in the global antipsychotic drugs market

The key players dominating the global antipsychotic drugs market are AstraZeneca, Pfizer, Inc., Eli Lily and Co., Bristol- Myers Squibb, Johnson & Johnson, GlaxoSmithKline, and Allergen. These players are involved in developing innovative drugs for treatment of psychotic diseases with reduced side effects of the drugs to increase the consumption of the product in market. Otsuka Pharmaceuticals in November 2017 received an FDA approval for the first ever antipsychotic drug treatment Abilify MyCite, which is imbued with a digital ingestion tracking system that intends to treat Schizophrenia and acute attacks of bipolar disorder.

ANTIPSYCHOTIC DRUGS MARKET ANALYSIS

Leading Companies

Antipsychotic Drugs Market Report Snapshots

EXISTING CLIENTELE